In an article published in Nature Communications, Francesca Rapino & Pierre Close, from the Laboratory of Cancer Signaling (GIGA), discover how the modification of transfer RNAs impacts the dynamics of protein expression.
The Alzheimer's Research Foundation has selected three research projects at the University of Liège for a total of 600,000 euros, out of the 3,200,000 euros granted by the Foundation in Belgium.
The company CMD-Coat S.A., born from a collaboration between the GIGA (GIGA-Cardiovascular), the CHU (cardiology service) and the ULiège chemistry department, was officially born this 25th March.
A research project conducted in close collaboration with the SCK-CEN has developed a process that provides a more effective measurement of a worker's radiation level than the traditional dosimeter.
Michael Herfs' team (Lab for Experimental Pathology, GIGA-Cancer) demonstrates the importance of blocking the oxidized form of this protein to reactivate anti-tumor immunity and improve the effectiveness of immune checkpoint inhibitors.
A grant that will enable them to study certain mechanisms responsible for the disability induced by multiple sclerosis.
GIGA is part of this H2020 project. Liesbet Geris, introduced the OcDefects solution, a computational model to be used for In Silico trials of an Advanced Therapeutic Medicinal Product for the repair of deep osteochondral defect.
This grant will allow him to continue his research in order to study the role(s) of mTORC2 in mRNA translation and cellular metabolism, in the context of lung cancer development.
Anne-Simone Parent’s team illustrates the consequences of exposure to these compounds on the neuroendocrine system controlling puberty and reproductive functions in Nature Reviews Endocrinology.
Laurent Nguyen's team (Laboratory of Molecular Regulation of Neurogenesis - GIGA-Stem Cells) reveals the importance of neuronal transport and local translation processes for the formation and proper functioning of synapses.
This is what Christophe Desmet and his team demonstrate in 2 recent publications (J Immunol and J Exp Med).
These results will help researchers to identify at an early stage the people most at risk of developing the disease, well before the first cognitive symptoms appear.